KOL Leadership Platform

Reinvigorate a Declining Tumor Franchise Ahead of New Product Launch

Mission: 

• Assemble leading global oncologists under a strategic platform
• Ensure complete alignment through NMP local activities
• Support targeted working groups, regional symposia and online Portal

Key Issues:

• Existing drug on the market for over 20 years is the only approved therapy for a specific cancer tumor area
• Despite this, confusion reigned over true clinical benefit with -Europeans lagging significantly behind US in use and acceptance
• Client preparing to launch new drug in this tumor area and needs to re-establish itself as a true partner to this oncology community

Results and Implications:

• Sales increase by 76% after one year is directly attributed by client to disease platform
• KOLs have communicated their excitement and pride in collaborating in such an impactful manner
• A supplement consisting of 9 expert opinion articles published in a major European oncology Journal
• Full franchise support reaching out to local KOLs by organizing symposia in all major geographic areas (Europe, South America, Asia, Australia)